HELP     Sign In

Xq11.1-q11.2CNV Type: Deletion


Largest CNV size: 216700 bp

Statistics Box:
Number of Reports: 2



Summary Information

A de novo deletion involving the ARHGEF9 gene was identified in an 18-year-old male patient presenting with autism, severe intellectual disability, and epilepsy (Machado et al., 2015).

Additional Locus Information

Genome browsers

USCS Symbol             NCBI Symbol

Decipher

            Decipher Symbol

References

Major Reports

Title
Author, Year
Report Class
CNV Type
Collybistin binds and inhibits mTORC1 signaling: a potential novel mechanism contributing to intellectual disability and autism.
Deletion

Minor Reports

Title
Author, Year
Report Class
CNV Type
Xq11.1-11.2 deletion involving ARHGEF9 in a girl with autism spectrum disorder.
Deletion

Cases

Cohort ID
Author, Year
Descripton
Cohort Size
Diagnosis
Age
Gender
CNV Size
Deletion
Duplication
Total CNV's
 bhat_16_ASD/ADHD/DD/ID_discovery_cases
 Female patient born to non-consanguineous parents of Mexican ancestry with non-contributory family history
 1
 Case diagnosed with ASD at age of 6 years (GARS-2) and with ADHD at 5 years (Commers' ADHD Rating Scale) and presented with global developmental delay and mild intellectual disability (formal IQ test N/A)
 8 yrs.
 Female
 82000
 1
 0
 1
 machado_15_ASD/ID/EP_discovery_cases
 Only child of healthy non-consanguineous parents presenting with autism, severe intellectual disability, and epilepsy
 1
 Case presents with autism, severe intellectual disability, and epilepsy. Diagnosis of autism by Childhood Autism Rating Scale (CARS score of 34.5, indicating mild-to-moderate autism); Vineland Adaptive Behavior Scales second edition (VABS-II) revealed severely deficient adaptive behavior (VABS-II composite score of 32)
 18 yrs.
 Male
 216700
 1
 0
 1

Controls

No Control Data Available

Cases

Cohort ID
Geographical Ancestry
Discovery Method
Platform
Algorithm
Software
Validation Method
 bhat_16_ASD/ADHD/DD/ID_discovery_cases
  Mexican
 Array SNP
  Affymetrix CytoScan HD
 
 
 None
 machado_15_ASD/ID/EP_discovery_cases
  Caucasian
 aCGH
  Agilent 44K
 
 
 Solid phase hybridization (Illumina CytoSNP 850K BeadChip)

Controls

No Control Data Available

Cases

Patient ID
Author, Year
Age
Gender
Primary Diagnosis
Clinical Profile
Cognitive Profile
CNV Start
CNV End
CNV Size
Genome Build
Type Method
Validation
  bhat_16_ASD/ADHD/DD/ID_discovery_cases-case1
 8 yrs.
 F
 ASD, ADHD, developmental delay and intellectual disability
 Case diagnosed with ASD at age of 6 years (GARS-2) and with ADHD at 5 years (Commers' ADHD Rating Scale). Birth/neonatal history: born at term via spontaneous vaginal delivery following uncomplicated pregnancy; birth weight of 3400 g (50th %ile); uneventful neonatal period. Developmental milestones: walked at 16 months, first words at 2 years of age. Language and communication evaluation: severe speech impairment; vocabulary limited to about 20 words, unable to combined words together, communicated by pointing, reported to be making progress with assistance of speech therapy; poor comprehension of verbal instructions. Behavioral/psychiatric evaluation: behavioral issues first noticed at 3 years of age; multiple sensory sensitivities based upon Short Sensory Profile; lack of social interaction; poor eye contact; hand flapping when excited; shyness around new people; occasional temper tantrums. Epilepsy/seizures: no history of seizures. Dysmorphic features: none noted on physical exam. Family history: non-consanguineous parents of Mexican ancestry; non-contributory family history.
 Mild intellectual disability (unable to perform a formal IQ test)
 63750691
 63832816
  82126
 GRCh38
 Deletion
 No
  machado_15_ASD/ID/EP_discovery_cases-case1
 18 yrs.
 M
 ASD, ID, and epilepsy
 Diagnosis of autism by Childhood Autism Rating Scale (CARS score of 34.5, indicating mild-to-moderate autism). Behavioral/psychiatric evaluation: Vineland Adaptive Behavior Scales second edition (VABS-II) revealed severely deficient adaptive behavior (VABS-II composite score of 32). Epilepsy/seizures: seizures under control with medication (valproic acid). EEG: focal epileptifrom discharges that were maximal over left frontocentral head region. Dysmorphic features: none. Family history: only child of healthy non-consanguineous parents.
 Severe intellectual disability; IQ test could not be taken properly owing to severity of ID
 63636294
 63852981
  216688
 GRCh38
 Deletion
 Yes

Controls

No Control Data Available

Cases

Patient ID
Validation Description
Primary Disorder Inheritence
Inheritence
Family Profile
Disease Segregation
Gene Content
Altered Gene Expression
 bhat_16_ASD/ADHD/DD/ID_discovery_cases-case1
 
 
 De novo
 Simplex
 Likely segregated
 BTF3P8,MIR1468,ARHGEF9
 
 machado_15_ASD/ID/EP_discovery_cases-case1
 Solid phase hybridization (Illumina CytoSNP 850K BeadChip)
 
 De novo
 Simplex
 Segregated
 ARHGEF9-IT1,BTF3P8,MIR1468,ARHGEF9
 iPSC-derived neural progenitor cells showed complete loss of ARHGEF9 expression

Controls

No Control Data Available
No Animal Model Data Available
HELP
Copyright © 2017 MindSpec, Inc.